Search company, investor...

Predict your next investment

Corporation
ventura-biomed.com

Investments

5

About Ventura BioMed Investors

Ventura BioMed Investors invests in early-stage life science companies developing pioneering technologies and innovative therapies.

Headquarters Location

Germany

Want to inform investors similar to Ventura BioMed Investors about your company?

Submit your Analyst Briefing to get in front of investors, customers, and partners on CB Insights’ platform.

Latest Ventura BioMed Investors News

Kupando Raises €13 Million in Series A Funding Round

Sep 26, 2022

Financing led by Remiges Ventures, co-led by LifeCare Partners, with additional investments by Brandenburg Kapital, High-Tech Gründerfonds, Ventura Biomed Investors and undisclosed family offices. Proceeds to be used to complete IND-enabling work and initiate clinical development. SCHÖNEFELD/BERLIN, Germany, September 26, 2022 / B3C newswire / -- Kupando , a pioneering biopharmaceutical company developing TLR 4/7 agonists that stimulate innate immunity for use in oncology and infectious diseases, announces today the closing of its Series A funding round which raised €13 million. The funds will be used to complete IND-enabling work and to initiate the clinical development of Kupando’s lead candidate ...

Ventura BioMed Investors Investments

5 Investments

Ventura BioMed Investors has made 5 investments. Their latest investment was in Navignostics as part of their Seed VC on November 11, 2022.

CBI Logo

Ventura BioMed Investors Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

11/9/2022

Seed VC

Navignostics

$7.6M

Yes

1

10/6/2022

Seed VC

Subscribe to see more

$99M

Subscribe to see more

10

9/26/2022

Series A

Subscribe to see more

$99M

Subscribe to see more

10

7/25/2022

Series A

Subscribe to see more

$99M

Subscribe to see more

10

10/14/2021

Series A - II

Subscribe to see more

$99M

Subscribe to see more

10

Date

11/9/2022

10/6/2022

9/26/2022

7/25/2022

10/14/2021

Round

Seed VC

Seed VC

Series A

Series A

Series A - II

Company

Navignostics

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Amount

$7.6M

$99M

$99M

$99M

$99M

New?

Yes

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Co-Investors

Sources

1

10

10

10

10

Ventura BioMed Investors Team

1 Team Member

Ventura BioMed Investors has 1 team member, including current Chief Executive Officer, Andreas Jenne.

Name

Work History

Title

Status

Andreas Jenne

Chief Executive Officer

Current

Name

Andreas Jenne

Work History

Title

Chief Executive Officer

Status

Current

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.